| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68be76dd063e3301487afa70ea3f2975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ac8fd11f8c0a5f7ed3ada552f111e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a413ada013df86cc77aa03d813f017d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 |
| filingDate |
2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62b6ba59cec71ab6c52d81201b19ce98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5de07934740c6282ec774df0743c8be1 |
| publicationDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013044246-A1 |
| titleOfInvention |
Buffered upper gi absorption promoter |
| abstract |
The present invention relates to compositions of an active pharmaceutical compound or nutritional ingredient with one or more buffering agents between a pH of 1.0 and 6.0, preferably 2.0 and 4.0. The buffering agents are constituted to maintain or reduce the pH of the duodenal fluid in the proximal, mid and distal duodenum. The present invention further relates to methods of improving the absorption of an iron compound or an active pharmaceutical compound within the small intestine. The present compositions and methods improve absorption or bioavailability of the administered compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017232266-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019511572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017158030-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190006946-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102403292-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7193145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014197250-A1 |
| priorityDate |
2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |